Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · April 15, 2023

Incident Cancer Risk in Patients With Diabetes Receiving and Not Receiving SGLT2 Inhibitors

Journal of Diabetes and its Complications

 

Additional Info

Journal of Diabetes and its Complications
Patients with diabetes with and without sodium-glucose cotransporter-2 inhibitors use with incident cancer risk
J Diabetes Complicat 2023 May 01;37(5)108468, WS Hu, CL Lin

Further Reading